In addition, circHECTD1 suppression can also significantly reduce cerebral infarct size in mice with transient middle cerebral artery occlusion through the MIR142/TIPARP pathway, reduce neuronal damage, and promote the activation of astrocytes [39]. The gene discussed is TIPARP; the disease is brain infarction.